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ABSTRACT 
Estimating evolutionary conservation of cleavage site peptides among HA protein of all 
strains facilitates vaccine development against pandemic influenza. Conserved epitopes 
may be useful for diagnosis of animals infected with the influenza virus, and preventing 
their spread in other regions [ 1]. In the preliminary stage of this study, in silico analysis 
of hemagglutinin was applied to predict potential cleavage sites of each strain employing 
SigCleave [2] and SignalP 3.0 server [3]. The second stage of the study focused on 
analyzing the structure of connecting peptides of hemagglutinin cleavage sites based on 
the availability of the existing experimental data. Our result divulges higher frequency of 
base amino acids, essential for processing by the cellular protease, among pathogenic 
strains compared with non/low pathogenic strains. In addition, two complementary 
methods for identifying conserved amino acids were applied: statistical entropy based 
method, possibly the most sensitive tool to estimate the diversity of peptides [5], and 
relative entropy estimation. Analysis of both methods demonstrates that the connecting 
peptide of HA cleavage site of AIV in the United States were highly conserved over long 
periods of time. Entropy values aid to select those sequences that have the highest 
potential for mutation in a broad spectrum of avian population. Position 340 among our 
group of strains with the entropy value of 0.877928 has the highest bit of information 
value where highly conserved positions are those with H <1.0 [4]. Mutual information 
and Pearson Chi-squared were also estimated to measure the independence between two 
adjacent columns (M (Ci, Ci+ I)) in the cleavage site connecting peptides. 
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RATIONALE 
Avian influenza viruses (AIV) characterized by intravenous pathogenicity indices of 
greater than 1.2 are termed highly pathogenic l61. The virulence of avian influenza A
viruses depends on the cleavability of the haemagglutinin (HA) by an intracellular 
protease at multiple basic amino acids. Although previous studies have demonstrated the 
importance of these amino acids for processing by the cellular protease, with emphasis on 
conserved residues near the cleavage site, the minimal requirements for cleavage remain 
unknown121 . Virulent avian influenza viruses, restricted to the HS and H7 subtypes, cause 
systemic, lethal infection in poultry, whereas mammalian and avirulent avian viruses 
cause local infection in the respiratory or intestinal tract or both 181. In the US, the
isolation of HS and H7 subtypes avian influenza (Al) viruses have been uncommon in 
commercial chickens and turkeys, although sporadic isolations have been made from the 
live bird markets or its supply chain since 1986. In 2002, two different outbreaks of HS 
AI occurred in commercial chicken or turkey operations. The first outbreak occurred in 
Texas and was identified as a HSN3 subtype AI virus. The second one was caused by a 
HSN2 virus isolated from a turkey farm in California m. Rapid typing of the 
pathogenicity of avian influenza A viruses of subtype HS is crucial to initiate adequate 
protective measures preventing the spread of highly pathogenic AIV (HPAIV) 1101.
Motivated by the need for a better understanding of the influenza genome, this project is 
designed to identify the genetic diversity of cleavage sites of HS subtype avian influenza 
(AI) viruses in the United States. 
1. INTRODUCTION & BACKGROUND
Infections with influenza A viruses continue to be a public health problem, causing 
seasonal epidemics and sporadic but devastating pandemics. Influenza is responsible for 
about 36,000 deaths and more than 200,000 hospitalizations in the US each year 111-121 .
Recent studies have also found the illness may trigger up to 92,000 cardiac deaths per 
year nationwide. 1131 In addition, the disease results in more than $87 billion of U.S.
economic burden annually 1141 . Influenza viruses have evolved in association with their 
various hosts in different continents for extended periods of time 1151. This co-evolution 
has resulted in extensive genetic divergence among the extant viruses currently available 
for analysis. 
Influenza viruses belong to the family Orthomyxoviridae and are classified into three 
types A, B and C based on the identity of major internal protein antigens 1161.They are
extremely adept at surviving in the inter or intraspecies through several periods of time. 
Adaption is non-exclusive for influenza A and C in that being adapted within a particular 
species does not prevent adaptations to other host species but influenza B virus is almost 
exclusively a pathogen of a human 1171. Influenza B and C viruses are generally less 
pathogenic than influenza A viruses. Phylogenetic analysis of nucleoproteins and 
polymerase proteins however has indicated that influenza A and B viruses are more 
related to each other compared with influenza C viruses 1181.
New influenza virus variants result from frequent antigenic changes. The avian influenza 
virus can improve its transmissibility among humans by two mechanisms. The first one is 
antigenic shift, a "reassortment" event in which genetic material is exchanged between 
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human and avian viruses during coinfection of a human or pig. Reassortment could result 
in a fully transmissible pandemic virus, which could rapidly spread throughout the world. 
The second mechanism is more gradual and is called antigenic drift, an adaptive 
mutation. Antigenic drift results from point mutations that occur during viral replication. 
It is these frequent antigenic changes through antigenic drift that require a new influenza 
vaccine be given each year 1191. This adaptive mutation expressed among human
population give the world some time to take defensive action (WHO). 
Avian influenza, commonly known as bird flu or avian flu refers to "influenza caused by 
viruses adapted to birds" l161l171120-241. Avian influenza viruses occur naturally among wild
birds worldwide. Transmission of avian influenza occurs between chickens and humans 
as well as pigs and humans. However transmission has not been seen between wild birds 
and humans 1191. Until 1997, the risk of avian influenza was considered to be rare in
humans although confirmed cases of human infection from several subtypes of avian 
influenza infection have been reported since 199?1181. All known viruses that cause
influenza in birds belong to influenza type A but influenza A viruses are hosted by 
numerous avian and mammalian species which have shaped their evolution into distinct 
lineages worldwide. Influenza A viruses cause the greatest morbidity and mortality in 
humans. Interestingly, the largest pool of influenza A viruses is maintained by horizontal 
spread in wild aquatic birds in which the virus does not normally cause any disease11611251.
Since the virus is mutating from time to time, existing vaccines are losing their 
functionality and becoming ineffective on a regular basis, requiring new vaccines to be 
developed from new strains. In other words, whenever a new strain of influenza emerges, 
the current vaccines are rendered largely ineffective and a flu pandemic can occur 1261 .
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Less-frequent major changes, known as antigenic shift, create new strains against which 
the human population has little protective immunity, thereby causing worldwide 
pandemics [221.
There are two types of avian influenza (Al) that are identified as HSN I. A difference 
exists in the virus classification; one is low pathogenic (LPAI) and the other is highly 
pathogenic (HPAI). Pathogenicity refers to the ability of the virus to produce disease. 
LPAI, or "low path" AI, commonly occurs in wild birds. In most cases, it causes minor 
sickness or no noticeable signs of disease. It is rarely fatal in birds. LPAI strains are not a 
human health concern. HPAI, or "high path" AI, spreads rapidly and is often fatal to 
chickens and turkeys. Millions of birds have died in countries where HPAI HSNI has 
been detected. This virus has also infected people, most of whom have had direct contact 
with infected birds l271. Evidence of LPAI HSN I has been found in wild birds in the
United States in recent years and is not closely related to the more severe HPAI HSNl 
circulating overseas 1271. Fortunately, HPAI HSN 1 has not been detected in the United
States. However, other strains of HPAI have been detected and eradicated three times in 
the United States: in 1924, 1983 and 2004. No significant human illness resulted from 
these outbreaks. HPAI, or "high path" Al, spreads rapidly and is often fatal to chickens 
and turkeys. The 1983-84 HPAI HSN2 outbreak resulted in humanely euthanizing 
approximately 17 million chickens, turkeys and guinea fowl in Pennsylvania and Virginia 
to contain and eradicate the disease. In 2004, USDA confirmed an HPAI HSN2 outbreak 
in chickens in Texas. The disease was quickly eradicated thanks to close coordination and 
cooperation between USDA and State, local, and industry leaders [271.
•
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The genome of the influenza A virus consists of eight single-stranded negative sense 
RNA molecules spanning approximately 13.5 kilobases (kb). The segments range m 
length from 890 to 2,341 nucleotides and encode a total of 11 proteins. 
Hemagglutinin(HA) and neuraminidase(NA) are two surface antigens which determine 
the subtype of influenza . Hemagglutinin mediates binding of the virus to target cells and 
entry of the viral genome into the target cell 1281• Hemagglutinin is the major envelope
glycoprotein of A and B viruses and hemagglutinin-esterase (HE) in C viruses is a protein 
homologous to HA. Influenza A virus HA genes are classified into 15 subtype (Hl-Hl6) 
according to their antigenic properties (WHO Memorandum 1980). In influenza type B 
and C virus HA (HE) genes are not classified into subtypes 1291. HA primarily serves for
the attachment of virus to cells and subsequently· for the penetration of viral components 
into the cells. The HA serves as a major antigen and elicits a strong immune response. It 
is synthesized as a single polypeptide chain of 550 amino acids with a molecular weight 
of 77 kD. Each monomer of the activated HA contains two chains: HAI and HA2 linked 
by a disulphide bond. Depending on the virus strain, host cell type and growth conditions, 
the precursor protein HAO can be proteolytically cleaved into HA l and HA2. This 
cleavage was reported to be essential for virus infectivity (Klenk et al., 1994; Zhirnov et 
al., 2002). The sensitivity of HA to host proteases is determined by the composition of 
the proteolytic site in the external loop of the HAO molecule which links HA I and HA2 
(Chen et al., 1998). This loop typically contains either a single Arg/Lys residue pair 
(monobasic cleavage site) or several Lys and/or Arg residues, with an R-X-K/R-R motif, 
forming a multibasic cleavage site. Influenza A viruses with multibasic cleavage sites 
(only HS, H7 subtypes) could be more virulent and induce systemic infection in hosts 
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than these viruses (all other influenza A viruses) with monobasic cleavage site (Klenk et 
al., 1994). Cleavage occurs either at the cell surface or on the released viruses. Former 
study has reported that the substitution of two nucleotides in the cleavage site region of 
A/chicken/GXLA/1204/05 completely abolished the signal generation 1101. Another study 
showed that deduced amino acid sequence at the hemagglutinin (HA) cleavage site of 76 
avian influenza (AI) viruses, subtypes H5 and H7, could reveal the pathogenicity of each 
strain. Importance of conserved amino acids at the cleavage site of the haemagglutinin of 
a virulent avian influenza A virus also focused on explaining the important role of amino 
acids in the cleavage site. 
Because influenza A virus pandemics in humans appear to occur when new subtypes of 
HA genes are introduced from aquatic birds, an understanding the structure of HA is of 
particular importance 1291. Reverse genetics provides direct evidence for a correlation of 
hemagglutinin cleavability and virulence of an avian influenza A virus(Horimoto T, 
Kawaoka Y., I: J Virol. 1994 May;68(5):3 l 20-8). Reverse genetics is an approach to 
discovering the function of a gene that proceeds in the opposite direction of so called 
forward genetic screens of classical genetics. Simply put, while forward genetics seeks to 
find the genetic basis of a phenotype or trait, reverse genetics seeks to find the possible 
phenotypes that may derive from a specific genetic sequence obtained by DNA 
sequencing 141. 
By exploiting the greatly increasing the number of publicly available complete influenza 
virus genomes, this project focuses on analyzing 116 protein sequences of cleavage site 
of H5 AI strains in the USA. The ultimate goal of this study is to attain insight into the 
fundamental sequence structure of the cleavage site of H5 avian influenza in the United 
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States. Understanding the trend of cleavage site change may distinguish the high 
pathogenic strains of AI from the low pathogenic ones. This hypothesis may also provide 
a different way to probe the enigma of pandemic influenza in the future. 
R ,ngs· 
P.i:.c: 
Soh 
Figure 1 1301: Ribbon representation of the hemagglutinin HAO trimer from the 1918 influenza
virus. Each monomer possesses two important sites: 1) the 'Receptor binding site' (blue shade) for 
virus attachment to the host lung epithelial cells via sialic acid containing host cell receptors. 2) 
The 'Cleavage site' where for full infectivity, the single chain (HAO) is cut into two chains (HAI 
colored red and HA2 colored green). At the N-terminal end of the HA2 chain is the fusion peptide 
which is critical for subsequent membrane fusion events that lead to infection. The 1918 HA 
monomer also possesses 2 basic patches (orange shade). 
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2. MATERIALS & METHODS
Bioinformatics analyzes 
Amino acid sequences of all HS proteins of avian influenza A viruses in the United States 
were downloaded from NCBI Influenza Virus Resources (Appendix Table A) 13 1l. Protein 
sequences are used in order to determine the changes of HA cleavage site since they are 
more conserved compare to nucleotide sequences. In this study MUSLE 1321 is used to do
the multiple sequence alignment (MSA) and align 116 strains of HS AI sequences. 
Multiple alignments of protein sequences are important in many applications, including 
phylogenetic tree estimation, structure prediction and critical residue identification. 
However, in this project the focus is on observing any specific changes including 
antigenic shift results from reassortment event or Antigenic drift results from point 
mutations in the cleavage site of HS AI. The result of the multiple sequence alignment is 
stored in a PASTA file (MSA). 
Using a Perl script (APPENDIX D), sequences and headers in the MSA PASTA file were 
isolated for further analysis. In this study, the location of cleavage sites and their 
positions along HA amino acid sequences were extracted by employing the predictor Perl 
module called SigCleave1331 and SignalP 3.0 server1341 . SigCleave predicts the location of 
cleavage site in each strain based on the (-3,-1) rule and SignalP 3.0 finds the cleavage 
site based on two other algorithms: an artificial neural network and a hidden markov 
model. The results of both programs then were compared with the existing cleavage site 
extracted by experimental methods. Before using predictions systems, it is necessary to 
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not only understand how the methods are constructed but also their strength and 
limitations. The prediction systems in humeral epitope discovery are still in their infancy, 
but have reached a reasonable level of predictive strength 1361.
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Figure 2: An overview of the methodology of this study. The process includes three major steps: 
i) extraction of amino acid sequences of all HA HS proteins of avian influenza A viruses in the
US ii) Extraction of surrounding cleavage site sequences employing SigCleave, SignalP 3.0 and
confirming the result with actual cleavage site sequences isolated by experimental methods iii)
entropy and relative entropy analysis of sequence variability and identification of conserved
peptide sequences of 8 amino acids at the cleavage site following by molecular analysis of
pathogenic and non/ low pathogenic group of strains and eventually test of independence for the
adjacent columns of the mature peptide of HA cleavage site.
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MUCSLE: 
MUSCLE employs two different distance measure for pair of sequences: A kmer, also 
known as k-tuple, distance for an unaligned pair and the Kimura distance for an aligned 
pair. A kmer is a contiguous subsequence of length k. Related sequences tend to have 
more kmers in common than expected by chance. The kmer distance is derived from the 
fraction of kmers in common in a compressed alphabet correlate well with fractional 
identity 1361. This measure does not require an alignment, giving a significant speed 
advantage. Given an aligned pair of sequences, MUSCLE computes the pairwise identity 
and converts to an additive distance estimate, applying the Kimura correction for multiple 
substitutions at a single site l37l. Distance matrices are clustered using UPGMA 1381, which
developers find to give slightly improved results over neighbor-joining 1391 , despite the 
expectation that neighbor-joining will give a more reliable estimate of the evolutionary 
tree. This can be explained by assuming that in progressive alignment, the best accuracy 
is obtained at each node by aligning the two profiles that have fewest differences, even if 
they are not evolutionary neighbors 1401.
In order to apply pairwise alignment to profiles, a scoring function must be defined on an 
aligned pair of profile positions. Let i and j be amino acid types, Pi the background 
probability of i, Pij the joint probability of i and j being aligned to each other, f\ the 
observed frequency of i in column x of the first profile, and f x G the observed frequency of 
gaps in that column at position x in the family (similarly for position y in the second 
profile). The estimated probability a\ of observing amino acid i in position x can be 
derived from f\ typically by adding heuristic pseudo-counts or by using Bayesian 
10 
methods such as Dirichlet mixture priors1411 . MUSCLE uses a new profile function which
is called the Jog-expectation (LE) score: 
LE
xy = (1 - f x c) (1 - f Y c) log � :Ej f \ f Yj Pi/Pi pjl 
This is a modified version of the log-average function 1421 :
LA xy = log :Ei :Ej a\ ayj Pi/Pi Pj2 
MUSCLE uses probabilities Pi and Pij derived from the 240 PAM VTML matrixes 1
441.
Frequencies f i are normalized to sum to 1 when indels are present (otherwise the 
logarithm becomes increasingly negative with increasing numbers of gaps even when 
aligning conserved or similar residues). The factor (1 - fG) is the occupancy of a column, 
introduced to encourage more highly occupied columns to align. Position-specific gap 
penalties are used, employing heuristics similar to those found in MAFFT and LAGAN 
1441. There are three main stages in the process of MSA algorithm: 
Stage 1: Draft progressive that produce a multiple alignment, emphasizing speed over 
accuracy. The kmer distance is computed for each pair of input sequences, giving 
distance matrix D 1 ( 1.1 ). Matrix D 1 is then clustered by UPGMA, producing binary tree 
TREEl (1.2). A progressive alignment is constructed by following the branching order of 
TREE L ( L .3). At each leaf, a profile is constructed from an input sequence. Nodes in the 
tree are visited in prefix order (children before their parent). At each internal node, a 
pairwise alignment is constructed of the two child profiles, giving a new profile which is 
assigned to that node. This produces a multiple alignment of all input sequences, MSA L, 
at the root. 
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Figure 3: This diagram summarizes the flow of the MUSCLE algorithm. There are three main 
stages: Stage I (draft progressive), Stage 2 (improved progressive) and Stage 3 (refinement). A 
multiple alignment is available at the completion of each stage, at which point the algorithm may 
terminate. 
Stage 2: Improved progressive: The main source of error in the draft progressive stage is 
the approximate kmer distance measure, which results in a suboptimal tree. MUSCLE 
therefore re-estimates the tree using the Kimura distance, which is more accurate but 
requires an alignment. The Kimura distance for each pair of input sequences is computed 
from MSAl, giving distance matrix D2 (2.1). Matrix D2 is clustered by UPGMA, 
producing binary tree TREE2 (2.3). A progressive alignment is produced following 
TREE2, producing multiple alignment MSA2. This is optimized by computing 
alignments only for subtrees whose branching orders changed relative to TREE I. 
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Stage 3: Refinement: This step iterates the process using Tree2. If the SP (Sum of pairs) 
score is improved, the new alignment is kept, otherwise it is discarded. 
An edge is chosen from TREE2 (edges are visited in order of decreasing distance from 
the root) (3.1). TREE2 is divided into two subtrees by deleting the edge (3.2). The profile 
of the multiple alignment in each subtree is computed. A new multiple alignment is 
produced by re-aligning the two profiles (3.3). If the SP score is improved, the new 
alignment is kept; otherwise it is discarded (3.4). Steps 3.1-3.4 are repeated until 
convergence or until a user-defined limit is reached. This is a variant of tree-dependent 
restricted partitioning 1401.
The process of multiple alignment can be terminated at steps one, two or three. The first 
two stages alone as MUSCLE-p, produces MSA2 with the time complexity O(N2L +
NL2) and space complexity O(N2 + NL + L2). Refinement adds an O(N3L) term to the
time complexity. 
MUSCLE is comparable in speed with CLUSTALW, completing a test set (PREFAB) 
averaging 49 sequences of length 240 in about half the time. The progressive method 
MUSCLE-p, which has average accuracy statistically indistinguishable from T-Coffee 
and the most accurate MAFFT script able to align 5000 sequences of average length 350 
in 7 min on a current desktop computer 1401.
SigCleave 
SigCleave is the program for identifying secretory signal sequences and also for 
predicting the site of cleavage between a signal sequence and the mature exported 
13 
protein. SigCleave is a program (originally part of the EGCG molecular biology package) 
that predicts signal sequences, and identifies the cleavage site based on the von Heijne 
algorithm, (-3,- l )-rule 1331 . This module is one the many modules available in the Bioperl
library. 
The predictive accuracy is estimated to be around 75-80% for both prokaryotic and 
eukaryotic proteins 1331. Three structurally and, possibly, functionally distinct regions
have been identified as the basic building-blocks of a secretory signal sequence: a basic 
N-terminal region (n-region), a central hydrophobic region (h-region), and a more polar
C-terminal region (c-region) 1451. The structural determinants for cleavage of the signal
sequence from the mature protein once export is under way seems to reside in the n- and 
h-regions, with positions -3 and -1 relative to the cleavage site being the most important
ones146.471. Indeed, this "(-3,-1)-rule" has been used to predict the most likely site of
cleavage directly from the primary sequence 1461.
Weight matrices construction 
Weight matrices are primarily used for pattern recognition in protein sequences and 
locate signals in nucleic acid sequences. Basically, one converts the observed number of 
each kind of residue in each position in a sample of aligned "signals" into a measure of 
the probability of finding that particular kind of residue in that particular position - the 
probability weight-matrix - by a suitable normalization. Then, any new sequence can be 
scanned by a moving window (looking up the respective probabilities in the weight­
matrix and multiply together for each position of the window) to get a measure of the fit 
to the sample used in the construction of the weight-matrix. The highest-scoring window-
14 
position is then taken as the prediction for the location of, the signal, if the score is above 
some minimum value 1331 . To score for possible signal sequence function, and to locate
the most probable cleavage site in a putative signal sequence, weight-matrices were 
constructed as follows. The raw amino acid counts for the two samples were divided by 
the expected number <N(a)> of each kind of residue given amino acid frequencies as in 
soluble proteins in general. Except for positions -3 and-1 relative to the cleavage site, all 
matrix elements with zero counts were normalized as ll<N(a)>. For positions -3 and -1, 
where there is good reason both from previous statistical and experimental studies to 
believe that only a subset of all residues are allowed 146•481 , the more stringent
normalization 1/N was used for the zero-count elements (where N is the total number of 
sequences in the sample). The final weight-matrix was obtained by taking the natural 
logarithms of the normalized values, thus reducing the ensuing probability calculations to 
summations rather than multiplications of the weight-matrix elements 1331.
The (-3,-l)-rule 
Based on previous statistics 1461, acceptable cleavage sites were suggested to conform to
the following rules: the residue in position -1 must be small (e.g. either Ala, Ser, Gly, 
Cys, Thr, or Gln) the residue in position -3 must not be aromatic (e.g. Phe, His, Tyr or 
Trp), charged (e.g. Asp, Glu, Lys, Arg), or large and polar (e.g. Asn, Gln). Further, it was 
suggested that Pro must be absent from positions -3 through + 1. The only exceptions 
found to date among eukaryotic proteins are one sequence with Leu in -1, one with Pro in 
-2, and three with Pro in -1. Thus, barring sequencing errors, the possibility that residues
other than the classical (-3,-1 )-kinds can be used in position -1, but only when no better 
cleavage site is available in the vicinity. 
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SignalP 3.0 Server 
SignalP predicts the presence and location of signal peptide cleavage sites in amino acid 
sequences from different organisms: Gram-positive bacteria, Gram-negative bacteria, and 
eukaryotes. The method incorporates a prediction of cleavage sites and a signal 
peptide/non-signal peptide prediction based on a combination of several artificial neural 
networks. It also incorporates predictions done by a hidden markov model designed to 
distinguish between signal peptides, non-secretory proteins, and (for eukaryotes only) 
uncleaved signal anchors. Motivated by the idea that the cleavage site position and the 
amino acid composition of the signal peptide are correlated, these algorithms were 
employed for SignalP 3.0 1341_
While HMMs are best at recognizing, in an 'elastic' fashion, the sequential pattern in the 
amino acids or nucleotides, the NN algorithms are better at handling sequence features 
correlated over a longer range, especially if there is some degree of conservation in the 
positioning of the relevant features. Together, the NN and HMM methods can therefore 
handle a very substantial part of the sequence diversity created by evolution that is 
characteristic for many complex biological mechanisms 1341 .
Artificial neural network 1341
Neural network input shows novel amino acid composition units as well as sequence 
position for better performance. It uses fivefold cross-validation tests for predicting the 
cleavage site. SignalP 3.0 server's performance is based on a combination of scores: Y, 
C, S and D-scores for the classification task. For each input sequence the neural network 
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(nn) module of signalp will first return three scores between O and 1 for each sequence 
position: 
C-score (raw cleavage site score)
The output score from networks trained to recognize cleavage sites vs. other sequence 
positions. Trained to be high at position +l(immediately after the cleavage site), and low 
at all other positions. 
S-score (signal peptide score)
The output score from networks trained to recognize signal peptide vs. non-signal-peptide 
positions (Trained to be high at all positions before the cleavage site and low at positions 
after the cleavage site and in the N-terminals of non-secretory proteins). 
Y-score (combined cleavage site score)
The prediction of cleavage site location is optimized by observing where the C-score is 
high and the S-score changes from a high to a low value. The Y-score formalizes this 
by combining the height of the C-score with the slope of the S-score. Specifically, the Y­
score is a geometric average between the C-score and a smoothed derivative of the S­
score (i.e. the difference between the mean S-score over d positions before and d 
positions after the current position, where d varies with the chosen network ensemble). 
Signalp-nn will then report the maximal C-, S-, and Y- scores, the mean S-score in the 
interval between the N- terminal and the site with the maximal Y-score and, finally, the 
D-score, the average of the S-mean and Y-max score.
All the above values give rise to separate predictions; they are reported together with the 
position of occurrence, the cutoff used to generate the specific prediction and the 
prediction itself. The final, combined prediction of the presence of a signal peptide in the 
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sequence is based on the D-score. If the sequence is predicted to have a signal peptide, 
the cleavage site is located immediately before the position with the maximal Y-score. 
Hidden Markov model 1491 
The Hidden Markov Model (HMM) of signal peptides contains submodels for the N­
terminal part, the hydrophobic region, and the region around the cleavage site. For known 
signal peptides, the model can be used to assign objective boundaries between these three 
regions. 
The hidden markov model (hmm) module of signalp will return posterior probabilities for 
cleavage site (C) and signal peptide (S) for each position in the input sequences. The 
cleavage site probability is the probability that a specific position is in the + l state, i.e. 
immediately after the cleavage site. In addition, the signal peptide probability is divided 
into three region probabilities: n-, h-, and c- region. This can be used to assign region 
boundaries to the signal peptides in the data set. For each sequence, signalp-hmm will 
report the overall signal peptide probability (this is equal to the posterior probability of 
signal peptide (S) for position 1). For eukaryotic data, the signal anchor probability is 
also reported. In addition, the maximal cleavage site probability is reported together with 
h · · h · 1491 t e pos1t1on w ere It occurs . 
The initial analytical part of the project focused on identifying possible deletions, 
intensity of amino acids and also particular type of amino acid property in the particular 
position of the specific serotype of HS AIV. The analysis followed by estimating the 
Shannon entropy and relative entropy of each residue at the particular position therefore; 
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identifying conserved and non-conserved residues. Calculation of mutual information 
also was done in order to identify the dependency of the amino acid residues in the 
sequence between two adjacent columns and Pearson Chi-squared test verified the result 
of dependency order in this project. 
Information theory approaches 
The diversity of the influenza A virus connecting peptide sequence was studied by 
creating subsets of the influenza A protein sequence alignments, comprising avian 
sequences, subdivided into two groups of pathogenic and low/non pathogenic. Assuming 
that each sequence represents an independent isolate, the information entropy 
methodology 1501 was used to measure the variability of cleavage site proteomes among
the strains in the context of overlapping eleven amino acid peptides surrounding the 
cleavage site. 
The rationale of this selection was the connecting peptides that are involved with virus 
pathogenicity. Applying Shannon's formula 131, the conserved amino acid entropy H(x) at 
any given position x in the alignment is computed by 
ll(X) := - L p(xi) logbp(1·i) 
i-1 
Where p(x) is the probability of a particular amino acid variant i being centered at 
position x (The fraction of residues of amino acid type i) on a finite set and n is the 
number of amino acid types (20). The entropy value increases with n(x), the total number 
of variants observed at position x; it is also sensitive to the relative frequency of the 
variants; such that it decreases when one variant is clearly dominant (i.e. the position is 
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conserved). The convention O log O is adopted in the definition. The logarithm is usually 
taken to the base 2, in which case the entropy is measured in "bits," or to the base e, in 
which case H(x) is measured in "nats." log2 is taken of the probabilities as this has 
several advantages when interpreting the results. By taking the log of the ratio, we can 
more easily capture the orders of magnitude. A second advantage is that we can express 
the result in terms of bits of information because we take log2 1511.
Shannon entropy measures the average minimum number of bits required to encode the 
information in the string. It estimates the average uncertainly of an outcome. The more 
repetition occurs in the string the more compression is possible and so the fewer are the 
number of bits needed to encode the information. In other words, the more conserved the 
site, the higher the information content. The likelihood that a pattern is meaningful 
(contains information) is derived as a measure of how often we might expect to see that 
pattern at random. However, the information content can sometimes be negative and so it 
is usually better to find information content using relative entropy 1521.
Relative entropy is also a method for finding unusual patterns in biological data. Relative 
entropy (rE) is commonly used in sequence comparison to quantify the degree of 
conservation l53-54l . It is derived from Shannon's general information entropy. In this 
case, relative entropy is an expression of the amount of information (observed 
probability) that each amino acid might encode in the given position of a sequence. 
Essentially, you ask "what is the probability that a given amino acid will occur at a given 
position based on what you have observed in your database of interest". Suppose there is 
a random variable (r.v.) with true distribution p. q represents the fraction of particular 
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amino acid in the genome (relative proportions).Then we could represent that r. v. with a 
code that has average length H(p). However, due to incomplete information we do not 
know p; instead we assume that the distribution of the r. v. is q. Then the code would need 
more bits to represent the r.v. The difference in the number of bits is denoted as D(p II q). 
The quantity D(p II q) comes up often enough that it has a name: it is known as the 
relative entropy1551.
The relative entropy or Kullback-Leibler distance between two probability distributions p 
and q is defined as: 
L p(.r) D(pll<J) :- p(.r)log-(-).q .l' .rc.X 
Where p and q be probability distributions with supports x and y respectively and ,l' c y 
Note that this is not symmetric, and the q (the second argument) appears only in the 
denominator. It may be shown that D(p II q)= 0 if and only if p(x)= q(x) for all value of x. 
Large value of entropy corresponds to sites which are conserved. In a similar fashion we 
may calculate the mutual information to find the conserved residues. Values close to zero 
(theory value) corresponds to a pair of sites which are conserved 1561.
In probability theory and information theory, the mutual information, or transinformation, 
of two random variables is a quantity that measures the mutual dependence of the two 
variables. The most common unit of measurement of mutual information is the bit, when 
logarithms to the base 2 are used. The mutual information also can be used for the test of 
dependency. The MC between two columns (I (xi, x i+ 1 )) measures the amount of 
dependence between the two columns. It is zero or close to zero if the columns are 
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independent. This is due to the fact that the columns of p are not that far from the value in 
relative proportions 1521.
Let p x and y be r.v.s with joint distribution p(x,y) and marginal distribution p 1 (x) and 
p2(y).The mutual information I (x; y) is the relative entropy between the joint distribution 
and the product distribution: 
I (x; y) = D(p(x, y) II p(x) p(y)) =
( p(x.y) )I(X; Y) = L L. p(.r, y) log p1 (:c) P2(Y) yEY xE,\ 
In the study of probability, given two random variables X and Y, the joint distribution of
X and Y is the distribution of the intersection of the events X and Y, that is, of both events
X and Y occurring together157l. 
If X and Y are random variables on X and Y respectively, the joint entropy of X and Y is 
H(X, }") = - I: p(.1'. u) lo&,1i(.r, y), 
(.1·,y)bl'xY 
Where p(x,y) denote the joint distribution of x and y. 
In this study, all strains that have deletion in the connecting peptide were removed before 
calculating entropy, relative entropy and mutual information however, gap were 
considered in order to get the most reliable, unbiased results. 
We might also have done a chi-squared test for independence for adjacent columns. The 
first step in the chi-squared test is to calculate the chi-square statistic. The chi-squared 
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statistic is calculated by finding the difference between each observed and theoretical 
frequency for each possible outcome, squaring them, dividing each by the theoretical 
frequency, and taking the sum of the results 1581.
,\2 = t (Oi - Ei) 2 
E· i=l 1 
Where O; = an observed frequency; Ei = an expected (theoretical) frequency, asserted by 
the null hypothesis and n = the number of possible outcomes of each event. 
The chi-square statistic can then be used to calculate a p-value by comparing the value of 
the statistic to a chi-square distribution. The number of degrees of freedom is equal to the 
number of possible outcomes, minus I. Having missing positions and also many gaps 
along the sequences, we may get an inaccurate p-value for the Chi-Square test although, 
we still can use Pearson's chi-squared values to tests of independence between two 
adjacent columns. A test of independence assesses whether paired observations on two 
variables, expressed in a contingency table, are independent of each other 1581.
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3. RESULTS & DISCUSSION
From predicting the cleavage site of 116 strains of HA sequence (Appendix Table A), 
using three different algorithms, the (-3,-1)-rule, neural network and Hidden Markov 
Model with eukaryotic matrix, 61.2 percent were detected to have a cleavage site 
between position 16 and 17 with the score of above 4.317 based on the (-3,- I )-rule and 
average maximum probability of 25.15 percent based on the artificial neural network 
algorithm. 38.8 percent either were not predicted to have a specific cleavage site or 
predicted to have a cleavage site with low probability (Appendix Table B). Figures 5 and 
6 show the output of SignalP and Sigcleave for Influenza A virus 
(A/gull/Pennsylvania/4175/83(H5Nl)  and Figures 6 and 7 show the output of both tools 
for Influenza A virus (A/turkey/Virginia/6962/83(H5N2). 
The reason of selecting these two strains is because of their assigned outputs by tools. In 
the first strain, the predicted cleavage site is the same by three algorithms however, in the 
later one, none of the tools predicted specific cleavage site. Artificial neural network in 
SignalP 3.0 server predicts the cleavage site and classifies the secreted and non-secreted 
sequences based on a combination of Y, C, S, C and D score. Considering the 
combination of scores, the maximum probability occurs between position 16 and 17 for 
influenza A/gull/Pennsylvania/4175/83 however, there is still very limited probability of 
having cleavage site around position 350. Also there might be a possibility that cleavage 
of HAO occurs after position 550. Hidden markov model predicts the cleavage site 
between position 16 and 17 with the Signal peptide probability of 0.244. SigCleave also 
reports two positions over score 3.5(the cut-off score): one with the score of 5.151 is 
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predicted between residues 4 to 16 and the other with the score of 4.317 between residues 
530 to 542.
Output o{Signa/P 3.0 Server for the Influenza A virus (A/gull/Pennsylvania/4175/83(HSNJ)) 
SignalP 3.0 Server-NN result for lcl_AAD 13575, length = 564 
�ion�lP-NN prPrlir.�in� ( PIJk nPt1.1nrk<.): l r.1 �ATI1��7S 
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Figure 4: Arrows represent the three predicted positions for the cleavage site based on the 
combination of scores. 
Measure Position Value Cutoff Signal peptide 
max. C 17 0.915 0.32 YES 
max. Y 17 0.728 0.33 YES 
max. S 1 0.907 0.87 YES 
mean S 1-16 0.648 0.48 YES 
D 1-16 0.688 0.43 YES 
Table 1: Represents the value of each score at the specific site based on neural network 
algorithm. Most likely cleavage site is between pas. 16 and 17: YKG-DQ 
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SignalP 3.0 Server-HMM result for lcl_AAD 13575 
SignalP-HMM prediction <euk models): lcl AAD13S7S 
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Figure 5: Arrow points the most possible cleavage site base on the combination of the scores. 
Prediction Non-secretory protein 
Signal peptide probability 0.248 
Signal anchor probability 0.000 
Table 2: Represents the signal peptide probability at the specific site based on hidden markov 
model algorithm. Max cleavage site probability: 0.244 between pos. 16 and 17 
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Output o{SigCleave for the Influenza A virus (A/gull/Pennsylvania/4175/83(HSNJ)) 
----------------------------------------------------------------
Sequence: AAD 13575 from: I to: 564 
HitCount: 2 
Reporting scores over 3.50 
------------------------------------------------- - ---- -------------
(I) Score 5.151 length 13 at residues 4-> 16
Sequence: IVlALAIISVVKG
I I 
4 16 
mature_peptide: DQICIGYHANNSTEQVDTIMEKNVTYTHAQDILEKEHNGKLCSLKGYRPL 
(2) Score 4.317 length 13 at residues 530->542
Sequence: SIYSTV ASS LALA
I I 
530 542 
mature_peptide: IMV AGLSFWMCSNGSLQCRICI 
The next three figures show that no significant score was found by any of the algorithms 
in order to predict the cleavage site for Influenza A virus A/turkey/Virginia/6962/83. 
These two types of results are very similar for most of the strains (Appendix Table B). 
23 strains in this study (low pathogenic, high pathogenic and unknown strains) were not 
predicted to have a specific cleavage site by any of the tools. 
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Output o(SignalP 3.0 Server for the Influenza A virus (Alturkey/Virginia/6962/83(HSN2)) 
SignalP 3.0 Server-NN result for lcl_AAF89536, length = 332 
SignalP-NN prediction (euk networks): lei AAF89536 
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Figure 6: Arrow shows the max C score of 0.254 at position 30 .Only C score is observable and 
probability values of other scores are very close to zero. 
Measure Position Value Cutoff Signal peptide 
max. C 30 0.254 0.32 NO 
max. Y 30 0.037 0.33 NO 
max. S 3 0.030 0.87 NO 
mean S 1-29 0.017 0.48 NO 
D 1-29 0.027 0.43 NO 
Table 3: Represents the value of each score at the specific site based on neural network 
algorithm. 
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SignalP 3.0 Server-HMM result for lcl_AAF89536 
SignalP-HMM prediction (euk models): lcl AAF89S36 
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Figure 7: No significant report was found 
Prediction Non-secretory protein 
Signal peptide probability 0.000 
Signal anchor probability 0.000 
Table 4: Represents the signal peptide probability at the specific site based on hidden markov 
model algorithm. Max cleavage site probability: 0.000 between pos. -1 and 0 
Output o(SigCleave for the Influenza A virus (A/turkey!Virginia/6962/83(HSN2)) 
------------------------------------------------------------------------------
Sequence: AAF89536 from: I to: 332 
HitCount: 0 
Reporting scores over 3.50 
SigCleave did not predict any significant hit over the threshold score to report as a potential 
cleavage site. 
Using prokaryotic matrix, SignalP 3.0 did not find a significant position to report for 
many strains (report file 4(Gram positive) and report file 5(Gram negative)) however, 
29 
SigCleave gave more hits in comparison with eukaryotic matrix (report file 3). Below are 
the outputs of both tools for Influenza A virus (A/mallard /MD/l 85/2003(H5N?)). 
Output of SignalP 3.0 for the Influenza A virus (A!mallard/Maryland/185!2003(HSN2)) 
SignalP 3.0 Server-NN result for lcl_ABV26006, length = 560 
SignalP-NN prediction (gram+ networks): lcl ABV26006 
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Figure 8: The combination of scores cannot report any particular position as a cleavage site. 
Measure Position Value Cutoff Signal peptide 
max. C 105 0.253 0.52 NO 
max. Y 25 0.195 0.32 NO 
max. S 4 0.734 0.97 NO 
mean S 1-24 0.312 0.51 NO 
1-24 0.254 0.45 NO 
Table 5: Represents the value of each score at the specific site based on neural network 
algorithm. 
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Output o(SigCleave for the Influenza A virus (A/mallard/Maryland/185/2003(HSN2)) 
------------------------------------------------------------------------------
Sequence: ABY26006 from: I to: 564 
HitCount: 6 
Reporting scores over 3.50 
------------------------------------------------------------------------------
(I) Score 6.121 length 13 at residues 138-> 150
Sequence: WSNHDASSGYSSA
I I 
138 150 
mature_peptide: CPYHGRSSFFRNYVWLIKKNNA YPTIKRTYNNTNYEDLLIIWGIHHPNDA 
(2) Score 5.575 length 13 at residues 530->542
Sequence: SIYSTY ASSLALA
I I 
530 542 
mature_peptide: IMIAGLSFWMCSNGSLQCRICI 
(3) Score 5.340 length 13 at residues 244->256
Sequence: FFWTVLRSNDAIS
I I 
244 256 
mature_peptide: FESNGNF!APEY A YKIVKKGNSAIMRSELEYGNCDTKCQTPVGAINSSMP 
(4) Score 4.968 length 13 at residues 526->538
Sequence: YQILSIYSTV ASS
I I 
526 538 
mature_peptide: LALAIMIAGLSFWMCSNGSLQCRICI 
(5) Score 4.108 length 13 at residues 33->45
Sequence: DTIMEKNYTVTHA
I I 
33 45 
mature_peptide: QDILEKEHNG KLCSLKGVRPLILKDCS V AGWLLGNPMCDEFLNVPEWSYI 
(6) Score 3.856 length 13 at residues 350->362
Sequence: GFIEGGWQGMVDG
I I 
350 362 
mature_peptide: WYGYHHSNEQGSGYAADKESTQKAIDGITNKVNSIIEKMNTQFEA VGKEF 
---------------------------------------
The last hit (number 6) for the Influenza A virus (A/mallard/MD/185/2003(H5N?)) given 
by SigCleave is the closet hit to the actual extracted cleavage site by experimental 
methods. It is predicted that cleavage site is between residues 350 to 362 with the score 
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of 3.856. This hit almost was predicted by SigCleave for each strain using prokaryotic 
matrix. In 2007, the study on characterization of Low-Pathogenicity HSN l Avian 
Influenza Viruses from North America observed two HA proteolytic cleavage site 
sequences in the wild-bird-origin viruses: 37 isolates had the sequence RETR/G, and 5 
isolates (A/Ruddy Turnstone /NJ/1851/01, A/Ruddy Turnstone/DE/2046/01, 
A/ShoreBird/DE/1346/01, A/Ruddy Turnstone/NJ/ 1698/01 and A/Ruddy 
Turnstone/NJ/1608/01 had the sequence RGTR/d591 (Appendix Table C). All these 42 
strains with the known cleavage site sequence are part of this study. However, no similar 
predicted cleavage site area was predicted by any of the tools. Previously, HP (Highly 
pathogenic) virus was derived from a LBM/93 isolate had a cleavage site sequence of 
RKTR/G (Horimoto & Kawaoka, 1995) which is not similar with the predicted site by 
the tools. 
Based on the previous studies, 81 strains were identified as low or non pathogenic strains 
and 6 as pathogenic strains of avian influenza in the USA in this study (Appendix Table 
C). 70 of these strains have the extracted connecting peptide sequence by experimental 
methods (Appendix Table C). The majority of low or non pathogenic strains have the 
PQ---RETR/GLF connecting sequence and minority of them has the following 
connecting peptides: PQ---REKRLF, PQKKKR/GLF, and PQ---RGTR/GLF. The 
pathogenic ones have either connecting sequence PQ---KKKR/GLF or PQ--­
RKKR/GLF. Although SignalP and SigCleave both predict the cleavage site between 
position 16 and 17 with the highest probability for many strains, the predicted peptide 
motifs are not matched with the actual cleavage site connecting sequences of influenza 
strains. However, we still get the small chance of having cleavage site around position 
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350, predicted cleavage site by experimental approaches (Figure 4). SignalP 3.0 server 
predicts the presence and location of signal peptide cleavage sites in amino acid 
sequences from different organisms: Gram-positive prokaryotes, Gram-negative 
prokaryotes, and eukaryotes but not viruses. The predictive accuracy in SigCleave is 
estimated to be around 75-80% for both prokaryotic and eukaryotic proteins although; the 
degree of accuracy is unpredictable for virus proteins. It is noteworthy that many studies 
have previously used both SignalP and SigCleave for viruses including influenza 160-621. 
By definition, the cell can recognize all kinds of protein sorting signals with almost 100% 
selectivity and specificity-the level of mis-sorting in vivo appears to be very low, 
although this aspect of the problem has not been studied in detail 1341. Given that the
sorting signals seem to be, at least to a good approximation, defined by a linear, N­
terminal stretch of the polypeptide, it would appear that one should be able to devise 
sequence-based methods that can recognize these signals with an efficiency approaching 
that of the cell itself. If such methods can be developed, they will clearly be of major use 
for genome analysis and automatic database annotation; at the same time, these massive 
data analysis tasks necessitate very accurate prediction methods. Phylogenetics analysis 
indicates that family of viruses does not have a specific phylogenetic clade. In addition, 
viri have multiple branches in the tree of life demonstrating that they are not 
monophyletic 191.Since virus nomenclature does not follow the standard genus + species
format, calling binomial() on viri, using bioinformatical tools for predicting cleavage site 
including SignalP 3.0 server and SigCleave portal is not advisable. The output will merge 
group name and species name, which is usually not what one expect. This definitely 
needs more work in the future 1341.
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The HAI gene of the HSN2 virus from Hong Kong (A/duck/Hong Kong/342/78(HSN2)) 
comprised I 026 nucleotide, as did the same gene from other non-pathogenic HS viruses 
(including US strains) examined in one study revealed that the pathogenic strain 
(A/tern/South Africa/ 61 (HSN3)), by contrast had a 12-nucleotide insertion at the 
cleavage site. Two HA I genes encoded proteins comprising 342 and 346 amino acids, 
respectively. DKHK78(A/duck/Hong Kong/342/78(HSN2)) featured a cleavage site 
sequence typical for nonpathogenic avian HS viruses (R-E-T-R), whereas the pathogenic 
TeSA61(A/tern/South Africa/ 61(HSN3)), was characterized by multiple basic amino 
acids at this site (R-E-T-R-R-Q-K-R), like the other pathogenic HS viruses used for 
analysis. Only partial sequences were obtained for the HA genes of two nonpathogenic 
HS isolates from the USA: nucleotide positions 545-775 for both DkMI80 
(A/duck/Michigan/80(HSN2)) and DkPA84 (A/duck/Pennsylvia/84(HSN2))1681 
Surprisingly, in this study, none of these strains were predicted to have a specific 
cleavage site with high probability. According to the SigCleave no score was identified 
over the threshold of 3.5 and based on the SignalP 3.0 the predicted cleavage site is 
between position 27 and 28 with the probability of 0.001 which is fairly close to zero. 
Therein, the deletion of nucleotides in sequences could be the other potential reason of 
getting inaccurate output from the predictor tools for influenza virus's sequences. In 
addition, it can be implied that the cleavage area was deleted through deletion therefore; 
virus did not get a chance to be cleaved to the host cell. 
The HA gene of the TX/04 isolate shared 98.6% amino acid identity with the TX/02 
isolate. However, the TX/04 virus had one additional basic amino acid (PQ---RKKR) 
(lysine at position 328 instead of a glutamic acid of the TX/02 (PQ---REKR) isolate) at 
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the HA cleavage site. TX/04 isolate possessed the same cleavage site sequence as the 
A/chicken/Scotland/S9, a known highly pathogenic AIV isolate 1631. The HA cleavage site
sequence of different isolates in North America in the other research reveals that they the 
cleavage site exist from position 321 to position 330. Also pathogen influenza A 
chicken/Pennsylvania/1370/ l983(HSN2) with the surrounding cleavage site sequence 
PQ---KKKR has the mature peptide of cleavage site from position 321 to 330 in addition 
with seven other influenza A strain collected nationwide 1631.
Nucleotide sequence analysis of HA cleavage site of the original avirulent strain of 
Mexican chicken HSN2 influenza virus revealed R-E-T-R, typical of avirulent viruses 
and unlike the K-K-K-R sequence characterizing viruses responsible for the 1983 
outbreak in poultry in the United States. By the end of 1994, the avirulent viruses had 
mutated to contain a highly cleavage hemagglutinin (HA) with mortality in poultry. Both 
mildly and highly pathogenic isolates contained insertions and a substitution of basic 
residues in the HA connecting peptide, P-K-R-K-T-R, which made the HA highly 
cleavable in trypsin-free chickens embryo fibroblasts 1641.
Most recent HS subtype isolates from US poultry shared a high sequence identity and 
phylogenetically assorted into a separate clade from the pathogenic Pennsylvania/83 
lineage isolates. The pathogenic Texas HSN3 isolate shared the lowest homology with 
the other recent isolates in the haemagglutinin gene and had a unique haemagglutinin 
cleavage site sequence of REKR/G (other recent isolates have the typical avirulent motif, 
RETR/G) 191. Comparison of the HA I sequence data for all available North American HS
subtype viruses demonstrated minimal variation both in and around the amino acids 
predicted to be involved in the HA receptor binding site. The proteolytic cleavage site 
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(PCS) is indicated at amino acid position 326 for all tested strain in the particular study 
1651. Surprisingly, in this study, the actual positions of extracted connecting peptides in the
multiple sequence alignment file exists between the ranges of position 337 to 347 among 
the influenza strains. The goal of this project is to investigate the characterization of the 
connecting peptide among avian influenza strains in the US therefore; this specific site in 
all strains was selected for further analysis. 
VELMA 
In order to analyze the mature peptide of a cleavage site, specific visualization tool, 
VELMA is employed. VELMA 1661, Visualization and E_xploration of Large Multiple
sequence Alignments, show individual amino acids by their one letter code, and uses 
color to indicate groups of amino acids. The tool uses the ClustalX algorithm for 
grouping/color schemes. 
l,L,M, V - green (these are small, hydrophobic amino acids) 
H,K,R - red (positively charged, hydrophilic amino acids) 
Y,W,F - blue (large and aromatic) 
G,P,S,T - orange (small) 
A,C,D,E,Q,N - white (the common feature of these is harder to specify) 
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Position 337 338 339 340 341 342 343 344 345 346 347 
Amino acid p p K K K R 
Amino acid H Q R G K * K R G L L 
Amino acid V * * E * * T * * G F 
Table 7: The above table shows the occurrences of the unique amino acids at the particular 
position in the connecting peptide of the AIV HSHA cleavage site. Star (*) represents null 
positions. 
Figure 11: Shows the intensity of the unique amino acid at the particular position among 116 
strain of HSHA avian influenza A proteins. The highlighted area represents the intensity of 
particular amino acid from position 337 to position 447. 
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Figure 12: Represents amino acid properties distribution bar in the cleavage site for low or non 
pathogenic avian influenza in the USA. A: Amino acid identity distribution by position B: 
Hydrophobicity distribution by position C: Polarity distribution by position D: Charge 
distribution by position E: Molecular weight distribution by position. 
Each column in the alignment is represented as a vertical histogram of amino acid 
property values, in hydrophobicity, polarity, charge and molecular weight. For example, 
second vertical histogram shows the hydrophobicity of amino acid (B). The height of 
each bar represents the proportion of sequences with a given value. The color is scaled 
with the property value: red for hydrophobic, blue for hydrophilic (Figure 12.B). 
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Amino P.Value P.Value P.Value P.Value
acid Position Hrdroehobicitr Fraction Polarity Fraction Charge Fraction MolWeight Fraction 
PRO I 337 -1.6 96.25 1.58 96.25 0 96.25 151.13 96.25 
337 51.6 1.25 1 1.25 
337 NA 2.5 NA 2.5 NA 2.5 NA 2.5 
338 -3.5 97.5 3.53 97.5 0 97.5 128.1 97.5 
338 NA 2.5 NA 2.5 NA 2.5 NA 2.5 
339 -4.5 95 52 95 1 95 174.2 95 
339 -3.9 2.5 
339 NA 2.5 NA 2.5 NA 2.5 NA 2.5 
340 -0.4 6.25 0 6.25 0 6.25 75.07 6.25 
340 -3.9 1 8.75 
340 -3.5 82.5 49.9 82.5 -1 82.5 147.13 82.5 
340 NA 2.5 NA 2.5 NA 2.5 NA 2.5 
341 -4.5 1.25 52 1.25 1 1.25 174.2 1.25 
341 NA 98.75 NA 98.75 NA 98.75 NA 98.75 
342 -3.9 1.25 51.5 1.25 1 1.25 146.19 1.25 
342 NA 98.75 NA 98.75 NA 98.75 NA 98.75 
343 -0.7 92.5 1.66 92.5 0 92.5 119.12 92.5 
343 -3.9 5 51.5 5 1 5 146.19 5 
343 NA 2.5 NA 2.5 NA 2.5 NA 2.5 
344 -4.5 97.5 52 97.5 1 97.5 174.2 97.5 
344 NA 2.5 NA 2.5 NA 2.5 NA 2.5 
345 -4.5 97.5 0 97.5 0 97.5 75.07 97.5 
345 NA 2.5 NA 2.5 NA 2.5 NA 2.5 
346 3.8 96.25 0.13 96.25 0 96.25 131.18 96.25 
346 NA 3.75 NA 3.75 NA 3.75 NA 3.75 
347 2.8 96.25 0.35 96.25 0 96.25 165.19 96.25 
347 NA 3.75 NA 3.75 NA 3.75 NA 3.75 
Table 8: Summarizes the probability value of amino acid's property at the particular position of 
the connecting peptide among low/non pathogenic AIV in the USA. Positive P-Yalues are 
highlighted with blue color. 
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Figure 14: Dot plot graphs: representing the mean property value of amino acid property among 
non/ low pathogenic strains. Red bars highlight the mean property value of specific property for 
the selected area. A) Amino acid identity distribution by position, B) Mean Hydrophobicity value 
dot plot graph, C) Mean Polarity value dot plot graph, D) Mean charge value dot plot graph, E) 
Mean Molecular Weight value dot plot graph. 
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Figure 15: Dot plot graphs representing the mean property value of amino acid property among 
pathogenic strains. Red bars highlight the mean property value of specific property for the 
selected area. A) Amino acid identity distribution by position, B) Mean Hydrophobicity value dot 
plot graph, C) Mean Polarity value dot plot graph, D) Mean charge value dot plot graph, 16.E) 
Mean Molecular Weight value dot plot graph. 
Comparison of the amino acid's characterization between two pathogenic and non/low 
pathogenic clusters( Figure 14 and Figure 15) reveals that all the properties remained 
almost the same between both groups however, the charge of amino acid was completely 
changed (Figure 14.D and Figure 15.D). It is surprising that the charge of amino acid at 
position 340 was positively increased in the pathogenic group of strains but it remained 
very low among the non/low pathogenic groups. 
HA major determinant of avian influenza virus virulence is the cleavability of the HA 
molecule (Klenk and Rott, 1998; Webster and Rott, 1987). The molecular basis for this 
property resides in the presence of multiple basic amino acids at the cleavage site 
(Kawaoka and Webster, 1998; Vay et al., 1992). Thus information on the cleavage site 
sequence of the isolated strains allows us to predict their virulence. Investigating the HA 
connecting peptide in this study, reveals that all of the pathogenic strains of influenza A 
have multiple base amino acid in the area. Thus, a series of basic amino acids at the 
cleavage site probably forms a recognition site for the enzyme(s) responsible for 
cleavage. Many of low/non pathogenic strains have only one base amino acid in their 
connecting peptide sequence RETR/G where Arginine is the only positively charged 
amino acid in the area. Higher P-value for the charge of amino acids in the mature 
peptide of the cleavage site among pathogenic strains in comparison with non/low 
pathogenic ones confirms this statement. It can be concluded that most probably the 
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charge of amino acids is more involved with pathogenicity of the particular strain than 
the other amino acid properties. Therefore, the surface glycoproteins of the pathogenic 
HS avian influenza viruses may have distinguishable properties although this statement is 
not always accurate. For instance, Influenza A virus (A/chicken/TX/167280-4/02(H5N3) 
with the cleavage site sequence PQREKR/GLF is categorized as low pathogenic 
influenza virus even thought, it has three base amino acid around the cleavage site: R,K 
and R. 
Information theory analysis 
Based on the information theory, the value of Shannon entropy, entropy and mutual 
information were calculated. The marked variability of influenza A virus surface 
proteins, the major targets of the neutralizing antibodies, have posed a serious obstacle in 
the development of effective and long-lasting influenza vaccine 1721. Thus, the primary
goal of estimating the Shannon entropy and relative entropy in this project was to identify 
viral connecting peptide sequences that have been conserved over long periods of time 
and to select those sequences that have the highest potential for mutation in a broad 
spectrum of avian population. 
In this study the columns that had more than 50% gaps were removed for information 
theory analysis in order to get the most reliable results. ·Table 10 shows the calculated 
values of Shannon entropy and relative entropy for the selected mature peptide of the 
cleavage site among all strains: 
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Position 338 339 340 
H 0.5342 0.6508 0.8779 
rE 2.9076 2.5777 1.8845 
341 
* 
* 
342 343 344 345 
* 0.6932 0.577 0.5342 
* 2.265 2.6403 2.225 
346 
0.6016 
2.0459 
Table 10: H stands for Shannon entropy and rE stands for Relative entropy values from position 
338 to 346. Columns 341 and 342 with the gap frequency of 0.616071 and 0.633929 among the 
sequences were removed in information technology analysis. 
330 350 360 
330 340 350 360 
Figure 16: Shows the Shannon entropy dot plot for the selected area (Red bars) using VELMA. 
H ranges from O (only one residue in present at that position) to 4.322 (all 20 residues are 
equally represented in that position) {Litwin and fores, 1992).Although in this study, this 
range can be varied from Oto 4.538016 since the proportion of gaps along the sequences 
were considered in calculations in order to get the most reliable degree of variability 
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Typically, positions with H _2::2.0 are considered variable, whereas those with H � 2 are 
consider conserved. Highly conserved positions are those with H �1.0 (Litwin and fores, 
1992). A minimum number of sequences is however required (-100) for H to describe 
the diversity of a protein family. 
Distribution of amino acid at any particular site is: 
H(x) = - P (o.o5) LOG2 (0.05) = 0.216096 
Thus: n is 0.2 I 6096*21 (20 amino acid and gap)= 4.538016 
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Figure 17: Scatter plot representing the calculated entropy values Vs the positions. This plot has 
been generated by Minitab. 
Both VELMA (Figure 16) and Minitab's dot plot graph (Figure 17) with the calculated 
values in this study reveals that every single amino acid in the mature peptide of the 
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cleavage site is highly conserved. They all have the entropy value of less than 1. 
However, this variability is more and less in different positions. For instance, position 
340 has the highest H value and positions 338 and 345 have the lowest H values. This 
means that position 340 is less conserved compared with the other positions around the 
cleavage site sequence. It is important to notice that position 340 is the same position that 
had the major change in charge of amino acid (Figure 15) among pathogenic strains 
versus the non/low pathogenic ones (Figure 14). This reveals that even though this 
specific position is highly conserved among the strains, a point mutation can cause the 
significant effect on the functionality of avian influenza A. 
Relative Entropies Vs Positions 
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Figure 18: Scatter plot representing the calculated relative entropy values Vs the positions. This 
plot has been generated by Minitab. The relative entropy values confirm the entropy values. 
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As expected, we get a low value at position 340 which means that this specific position is 
less conserved among the others so; the genetic diversity of amino acid has the highest 
rate of change at this particular position. In this specific position amino acid K (Lysine) 
has the occurrence frequency of 0.044643, G (Glycine) has the frequency of 0.044643 
and E (Glutamic acid) has the frequency of 0.544643. 
Distinct group of pathogenic and non/low pathogenic strains were analyzed separately 
(Figure 19 and Figure 20) to get the better spectrum of HAHS connecting peptide of AIV 
cleavage site in the USA. 
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Figure 19: The surrounding amino acid of HA cleavage site representing high variability at 
position 340 among low pathogenic strains of avian influenza in the USA. 
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Figure 20: The surrounding amino acid of HA cleavage site representing high variability at 
positions 337,339, 340 and 341 among pathogenic strains of avian influenza in the USA. 
Molecular comparison of both groups shows that pathogenic group of AIV has more 
fraction of base amino acid in the connecting peptide of the cleavage site. Thus, the 
hemagglutinin (HA) cleavage site of all pathogenic strains contained a series of basic 
amino acids that can be used to distinguish potentially pathogenic from avirulent avian 
influenza avian influenza viruses121 · This amino acid sequence is recognized by ubiquitous
intracellular proteases 151, allowing the virus to spread systemically in poultry.
Point mutation in influenza genome could indeed play an important role for virus's 
pathogenicity 169 1 . For example, comparing connecting peptide sequence of pathogenic
Influenza A virus Influenza A virus (Nchicken/Pennsylvania/1370/1983(H5N2)) 
PQKKKR/GLF, with low pathogenic Influenza A virus (A/chicken/TX/l 67280-
4/02(H5N3)), PQREKR/GLF, showed two base changes in the area. One is the change of 
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amino acid R to K and the other is the change of E to K. R and K are both positively 
charged, hydrophobic amino acids but E is small amino acid that was changed to base 
amino acid. Research on two nonpathogenic isolates from chickens revealed that HA 
protein (HAO) could not be cleaved into HA I and HA2 without trypsin. The sequences at 
the HA cleavage sites of Ck/PN93 (Nchicken/Pennsylvania/13609/93) and 
Ck/FLN93(Nchicken/Pennsylvania/ l 3609/93) (R-K-T-R) appear to be intermediate 
between those of virulent and avirulent viruses, raising the possibility that a single 
mutation could promote virulence in chickens 1701. However, point mutation among
Influenza A virus (Nshorebird/DE/1346/200 I (H5N7)), Influenza A virus (Nruddy 
turnstone/NJ/1698/2001(H5N7)), Influenza A virus (Nruddy 
turnstone/NJ/1851/2001 (H5N7)) and Influenza A virus (Nruddy 
turnstone/DE/2046/200 I (H5N8)) did not change the pathogenicity of influenza virus for 
the host. In the connecting peptide of all three, the Glutamic Acid in the RETR/G was 
changed to Glycine (RGTR/G). This mutation was not specific for the host, location or 
subtype although, it happened in 2001. 
From the information theory analysis, it can be concluded that mature peptides of the 
cleavage site among AIV in the USA are almost conserved but; there is high variability 
of amino acid at position 340. Analyzing the pathogenic cluster of strains however, 
revealed that a few positions have a higher entropy value which indicates higher rates of 
point mutation. This use of entropy methodology for identification of highly conserved 
protein sequences ushers a new experimental strategy in the development of vaccines for 
pathogens with the high rates of mutation. The comprehensive analysis of conserved 
sequences may also have other applications to pathogen diagnosis or therapy 1721. These
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sequences are known or can be presumed to have critical roles in viral survival and thus 
are choice targets for the development of antiviral agents 1721. Many reports, particularly
with respect to the human immunodeficiency virus type I (HIV-I) have described a 
strategic advantage in the use of computational analysis and conserved sequences for 
vaccine design I73-SOJ.
Mutual information and the test for dependence 
The result of dependency tests between two continues columns can be used to explore 
covarying positions in biological sequences of connecting peptide of HA and 
consequently improve the efficiency of next generation of vaccine. For this purpose, 
Mutual information and Pearson Chi-squared test were employed. Mutual information 
analyses may aid the prediction the rate of the amino acid change at the particular 
position along the multiple sequence alignment (Here mature peptide of the cleavage site) 
which could be very informative for preventing pandemic influenza in the future and 
improving novel generations of influenza vaccines. 
The mutual information between two adjacent column (M (Ci+Ci+ 1) measures the 
independent. Let Xi be the amino acid in position i (i= 338, 339 ... 346). We wish to 
investigate the mutual information, between adjacent columns for i=338 to 346. Using 
MI formula, previously described in the material section, the values of mutual 
information for two continuous columns in the connecting peptide of HA were calculated 
(Table 11). In addition, the Pearson Chi- Squared test for independence was done for 
adjacent columns (M (Ci+Ci+l)) (Table 11). The higher values of both tests show 
dependence and the lower ones show independence. The following plots show the mutual 
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information and Chi-squared test for the selected area of amino acid sequence around the 
cleavage site (Figure 21 and Figure 22). 
Position 
(i, i+l) 
MI 
Chi-
Squared V 
338-339
0.62605 
224 
339-340 340-341
0.51718 0.490977 
165.268 154.852 
341-342 342-343 343-344 344-345 345-346
0.41703 0.41703 0.510603 0.50767 0.53425 
112 112 185.61 185.585 224 
Table 11: Summarizes the Mutual information values as well as Pearson Chi-Squared values for 
the adjacent columns in the connecting peptide (Position 338-346). 
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Figure 21: Scatter plot graph shows the mutual information values at position i and i+ I in the 
mature peptide of the cleavage site. 
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Figure 22: Scatter plot graph shows the Pearson Chi-squared values at position i and i+ l in the 
mature peptide of the cleavage site. 
The similarity between the two plots infers that they provide quite similar information. 
The result shows that connecting peptide of HA cleavage site have an average mutual 
information value of 0.502598, which is not close to 0.0084294 l ( theory value) while the 
average for columns 341-342 and columns 342-343 is lower, demonstrating they are less 
dependent (Figure 21 ). Investigating the connecting peptide of the cleavage site in the 
multiple sequence alignment file shows that these two columns are the ones containing 
gap. This means that these positions are almost independent. The surprising point is that 
these columns do not exist in the connecting peptide among the high pathogenic strains of 
influenza (Figure 20). The same result was achieved employing Pearson Chi-squared test 
for dependence (Figure 22). 
54 
In addition, both plots indicate that other continues amino acid columns are fairly 
dependent although, some have the higher probability of being dependent (columns: 338-
339 and 345-346). The columns that have less dependency are exactly the same columns 
that had point mutations among the pathogenic strains compare with non/low pathogenic 
strains (Figure 20 and Figure 21). 
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Figure 23: Shows a plot of the estimated chi-squared values versus the mutual information with 
the linear fit. 
There is a linear relationship between the two statistics with the internal confidence of 
95%. Thus the Chi-Squared test and the mutual information, in this case, provide quite 
similar information. 
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It is noteworthy that some of the low pathogenic Influenza A viruses including 
(A/chicken/Pennsylvania/I/ l 983(H5N2)), (A/chicken/Pennsylvania/I/ I 983(H5N2)) and 
(A/chicken/Pennsylvania/ l / l983(H5N2)) have the same connecting peptide structure as 
the pathogenic Influenza A virus (A/chicken/Pennsylvania/ l370/I983(H5N2)) but they 
did not cause lethal infection in poultry in the USA. Also an avian influenza virus, 
A/turkey/England/50-92/91 (H5Nl ), showed extremely high virulence in chickens, 
although its hemagglutinin (HA) cleavage site sequence (R-K-R-K-T-R), having a 
nonbasic (Thr) residue at the second position (P-2) from the carboxyl terminus of HA 1, 
does not conform to the previously established consensus sequence motif, X-X-R/K-X­
R/K-R (X = nonbasic residue), for highly virulent phenotype of the HS virus. When 
scientists evaluated the HA cleavability of this strain in chicken embryo fibroblast 
culture, they observed that, unlike other HAs with a Thr residue at P-2, this HA was 
efficiently cleaved. These findings suggest that a nonbasic residue at the P-2 does not 
affect its recognition and catalyzation by cleavage enzymes that are otherwise influenced 
by satiric structure around the cleavage site f711• Therefore, although previous studies have
demonstrated the importance of these amino acids for processing by the cellular protease, 
with emphasis on conserved residues near the cleavage site, the minimal requirements for 
cleavage remain unknown121. 
There is no guarantee that pathogenic strains are host specific or subtype specific since 
influenza strains can be circulated in the world but, the isolated pathogenic strains in this 
study, were categorized in H5N2 subtype in the influenza genome bank except one case 
that belonged to H5N3 subtype. Also, they only caused the lethal infection among 
chickens, mallard duck and turkeys. In July 2007, USDA updated the news in regards 
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with this issue: Evidence of LPAI HSN 1 has been found in wild birds in the United States 
in recent years and is not closely related to the more severe HPAI HSN I circulating 
overseas. Fortunately, HPAI H5Nl has not been detected in the United States. However, 
other strains of HPAI have been detected and eradicated three times in the United States: 
in 1924, 1983 and 2004. HPAI, or "high path" AI, spreads rapidly and is often fatal to 
chickens and turkeys. The 1983-84 HP AI H5N2 outbreak resulted in humane! y 
euthanizing approximately 17 million chickens, turkeys and guinea fowl in Pennsylvania 
and Virginia to contain and eradicate the disease. In 2004, HPAI H5N2 outbreak 
happened among chickens in Texas. 
This study elucidates the identity of all the highly conserved sequences of mature peptide 
of the HA cleavage site among avian influenza A in the USA as the primary step in the 
selection of these sequences for the synthesis of a vaccine. We recommend two different 
tests for dependence between adjacent columns for two distinct groups of strains: 
pathogenic and low/non pathogenic as a second step in the future. Unfortunately, in this 
study, the small sample size of pathogenic strains (only six HA protein sequences) with 
the high similarity of amino acid at the particular position did not allow us to analyze 
them separately. 
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APPENDIX TABLE A 
AAB39639 564 HS 1982 Influenza A virus (A/Mallard/Wl/944/82) 
ABW96332 26 HS 2005 Influenza A virus (Alpintail/Alaska/284/2005(HS)) 
ABW96333 26 HS 2005 Influenza A virus (A/pintail/Alaska/772/2005(H5)) 
ABW96334 26 HS 2005 Influenza A virus (A/pintail/Alaska/779/2005(HS)) 
ABV26006 564 HSN 2003 Influenza A virus (A/mallard/MD/185/2003(HSN?)) 
AAD13572 564 HSNl 1981 Influenza A virus (A/duck/Minnesota/1525/1981 (HSN!)) 
AAD13575 564 HSNl 1983 Influenza A virus (A/gull/Pennsylvania/4175/83(HSN1)) 
ABV25966 564 HSNl 2006 Influenza A virus (A/black duck/NC/674-694/2006(HSNI)) 
ABV25967 564 HSN! 2005 Influenza A virus (A/duck/PA/454069/2005(HSN1)) 
ABV25968 564 HSN! 2006 Influenza A virus (A/mute swan/Ml/451072-2/2006(HSN1)) 
ABV25969 564 HSNl 20 4 Influenza A virus (A/wood duck/MD/04-623/2004(HSNI)) 
AAC58995 332 HSN! 1975 Influenza A virus (A/mallard/Wisconsin/428/1975(HSNI)) 
ABI84608 564 HSNl 1981 Influenza A virus (A/duck/Minnesota/1525/1981(HSNI)) 
ABJl6565 564 HSN2 2002 Influenza A virus (A/mallard/Maryland/789/2002(HSN2)) 
ABX88799 564 HSN2 2006 Influenza A virus (A/mallard/Maryland/182/2006(HSN2)) 
AAA43094 564 HSN2 1983 Influenza A virus (A/chick/Pennsylvania/l /1983(HSN2)) 
ABl84603 564 HSN2 1981 Influenza A virus (A/duck/Minnesota/1516/1981(HSN2)) 
BAF48359 564 HSN2 1984 Influenza A virus (A/duck/Pennsylvania/10218/1984(HSN2)) 
AAF89536 332 HSN2 1983 Influenza A virus (A/turkcyNirginia/6962/83(HSN2)) 
AAF89537 332 HSN2 1984 Influenza A virus (A/turkeyNirginia/40018/84(HSN2)) 
AAF89538 332 HSN2 1984 Influenza A virus (A/Chicken/Virginia/40018/84(HSN2)) 
AAF89539 332 HSN2 1986 Influenza A virus (A/Chicken/New Jersey/12508/86(HSN2)) 
AAF89540 332 HSN2 1986 Influenza A virus (A/Chicken/Pennsylvania/10210/86(HSN2)) 
AAF89541 332 HSN2 1986 Influenza A virus (A/chicken/Massachusetts/11801/86(HSN2)) 
AAF89542 332 HSN2 1986 lnfluen7.a A virus (A/Chicken/Ohio/22911-10/86(HSN2)) 
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AAF89543 332 H5N2 1986 Influenza A virus (A/chicken/Florida/277l6-2/86(H5N2)) 
AAF89544 332 H5N2 1987 Influenza A virus (A/Chicken/New York/12004-3/87(H5N2)) 
AAF89545 332 H5N2 1988 Influenza A virus fA/chicken/Florida/22780-2/88(H5N2)) 
AAF89546 332 H5N2 1989 Influenza A virus (A/chicken/Florida/2507 /89(H5N2)) 
AAC58996 548 H5N2 1981 Influenza A virus (A/turkey/Minnesota/3689-1551/198l (H5N2)) 
AAC58997 548 H5N2 1995 Influenza A virus (A/turkey/Minnesota/10734/1995(H5N2)) 
AAC58991 548 H5N2 1980 Influenza A virus (A/duck/Michigan/1980(H?N2)) 
AAC58992 332 H5N2 1988 Influenza A virus (A/mallard/Ohio/345/88(H5N2)) 
AB184784 564 H5N2 1982 Influenza A virus (A/mallard/New York/189/1982(H5N2)) 
AB184816 564 H5N2 1988 Influenza A virus (A/black duck/New York/184/1988(H5N2)) 
AB185095 564 H5N2 1983 Influenza A virus (A/chicken/Pennsylvania/l /1983(H5N2)) 
ABB80546 564 H5N2 2004 Influenza A virus (A/earrot/CA/6032/04(H5N2)) 
AAB82064 332 H5N2 1991 Influenza A virus (A/ruddy turnstone/Delaware/244/91(H5N2)) 
AAA74909 332 H5N2 1993 Influenza A virus (A/chicken/Pennsylvania/13609/l993(H5N2)) 
AAA74910 332 H5N2 1993 Influenza A virus (A/chicken/Florida/25717/1993(H5N2)) 
AAC54390 78 H5N2 1972 Influenza A virus (Aturkey/Coloradon2(H5N2)) 
AAC54391 77 H5N2 1984 Influenza A virus (A/d_uck/Pennsylvania/1984(H5N2)) 
AAC54392 78 H5N2 1980 Influenza A virus (A/duck/Michigan/1980(H5N2)) 
AAB49654 548 H5N2 1993 Influenza A virus (A/emuffexas/39442/93(H5N2)) 
AAB49655 550 H5N2 1993 Influenza A virus (A/emuffexas/39442/93(H5N2)) 
ABV25970 564 H5N2 1975 Influenza A virus (A/blue goose/Wl/711/1975(H5N2)) 
ABV25971 564 H5N2 2002 Influenza A virus (A/mallard/MDn90/2002(H5N2)) 
ABV25972 564 H5N2 2002 Influenza A virus (A/mallard/MD/865/2002(H5N2)) 
ABV25973 564 H5N2 2003 Influenza A virus (A/mallard/MD/185/2003(H5N2)) 
ABV25974 564 H5N2 2001 Influenza A virus (A/mallard/MD/252/200l(H5N2)) 
ABV25975 564 H5N2 2001 Influenza A virus (A/mallard/MD/258/2001(H5N2)) 
ABV25976 564 H5N2 2001 Influenza A virus (A/mallard/MD/302/200l(H5N2)) 
ABV25977 564 H5N2 2002 Influenza A virus (A/mallard/MDn86/2002(H5N2)) 
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ABV25978 564 H5N2 2002 lnnuenza A virus (A/mallard/MDn89/2002(H5N2)) 
ABV25979 564 H5N2 2002 Innuenza A virus (A/mallard/MD/79I/2002(H5N2)) 
ABV25980 564 H5N2 2002 Innuenza A virus (A/ma11arc1/MD/792/2002(H5N2)) 
ABV25981 564 H5N2 2002 lnnuenza A virus (A/mallard/MDn95/2002(H5N2)) 
ABV25982 564 H5N2 2002 Innuenza A virus (A/mallarc1/MD/866/2002(H5N2)) 
ABV25983 347 H5N2 2001 Innuenza A virus (A/ruddl turnstone/NJ/ l608/200 l(H5N2)) 
ABV25984 511 H5N2 2000 Innuenza A virus (A/mallard/MN/113/2000(H5N2)) 
ABV25985 564 H5N2 1998 Innuenza A virus (A/mallard/MN/133/1998(H5N2)) 
ABV25986 347 H5N2 2000 Innuenza A virus (A/mallard/MN/ l66/2000(H5N2)) 
ABV25987 343 H5N2 2000 Innuenza A virus (A/mallard/MN/168/2000(H5N2)) 
ABV25988 564 H5N2 2000 Innuenza A virus (A/mallard/MN/4 l0/2000(H5N2)) 
ABV25989 349 H5N2 2000 Innuenza A virus (A/mallard/MN/6/2000(H5N2}) 
ABV25990 347 H5N2 1988 Innuenza A virus (A/mallard/OH/345/1988(H5N2)) 
ABV25991 322 H5N2 1993 Innuenza A virus (A/2heasant/MD/4457/1993(H5N2)) 
ABV25992 322 H5N2 1998 Innuenza A virus (A/2heasant/NJ/9804563/1998(H�N2)) 
ABV25993 558 H5N2 2003 Innuenza A virus (A/ruddl turnstone/DFJ313/2003(H5N2)) 
ABV25994 347 H5N2 2003 Innuenza A virus (A/ruddy turnstone/DF1371/2003(H5N2)) 
ABV25995 564 H5N2 2007 Innuenza A virus (A/northern Eintail/FU598/2007(H5N2)) 
ABV26007 564 H5N2 2006 Innuenza A virus (A/mallard/W A/44242-264/2006(H5N2)) 
ABV25996 564 H5N2 2006 lnnuenza A virus (A/tundra swan/AK/44049-168/2006(H5N2)) 
AAF04719 564 H5N2 1984 lnnuenza A virus (A/mallard duck/PA/10218/84(H5N2)) 
AAF04720 564 H5N2 1984 Innuenza A virus (A/mallard duck/PA/10218/84(H5N2)) 
AAP71989 564 H5N2 1998 lnnuenza A virus (A/chukar/MN/14591-7/1998(H5N2)) 
AAP71990 354 H5N2 1998 lnnuenza A virus (AIEheasant/NJ/1355/98(H5N2)) 
AAP71994 339 H5N2 2000 lnnuenza A virus (A/Avian/NY/31588-2/2000(H5N2)) 
AAP71995 564 H5N2 2000 Innuenza A virus (A/Avian/NY/31588-3/2000(H5N2)) 
AAP71996 564 H5N2 2000 Innuenza A virus (A/Duck/NY/440 l8- l/2000(H5N2)) 
AAP7 l997 564 H5N2 2000 Innuenza A virus (A/ duck/NY/44018-2/00(H5N2)) 
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AAP71998 564 H5N2 2000 Influenza A virus (A/chukkar/NY/51375/00(H5N2)) 
AAP71999 332 H5N2 2000 Influenza A virus (A/Avian/NY/53726/2000(H5N2)) 
AAP72002 564 H5N2 2001 Influenza A virus (A/Duck/NJ/117228-7 /200 l(H5N2)) 
AAP72004 548 H5N2 2002 Influenza A virus (A/duck/ME/151895-7A/02(H5N2)) 
AAP72005 564 H5N2 20 2 Influenza A virus (A/Duck/NY/185502/2002(H5N2)) 
AAP72006 548 H5N2 2002 Influenza A virus (A/duck/NY/186875/02(H5N2)) 
AAP720 7 548 H5N2 2002 Influenza A virus (A/duck/NY/191255-79/02(H5N2)) 
AAP72008 548 H5N2 2002 Influenza A virus (A/turkcr/CA/D0208651-C/02(H5N2)) 
AAK57506 165 H5N2 1986 Influenza A virus (A/9uail/Oregon/207 I 9/86(H5N2)) 
AALl6033 251 H5N2 1984 Influenza A virus (A/ck/Washington/13413/84(H5N2)) 
AAX47288 564 H5N2 2004 Influenza A virus (A/chickenffX/298313/04(H5N2)) 
ABG88245 564 H5N2 1988 Influenza A virus (A/wigeon/Ohio/379/1988(H5N2)) 
ABW94105 564 H5N2 2000 Influenza A virus (A/Avian/NY/53726/2000(H5N2)) 
ABW97492 564 H5N2 1992 Influenza A virus (A/turker/MN/3397-3/1992(H5N2)) 
AAA43159 547 H5N2 1983 Influenza A virus (A/chicken/Pennsrlvania/1370/198_3(H5N2)) 
AAA43160 547 H5N2 1983 Influenza A virus (A/chicken/Pcnnsrlvania/l /1983(H5N2)) 
AAP72009 548 H5N3 2000 Influenza A virus (A/ruddy turnstonc/NJ/2242/00(H5N3)) 
AAP72010 548 H5N3 2002 Influenza A virus (A/chickenffX/167280-4/02(H5N3)) 
ABV25997 347 H5N3 2000 Influenza A virus (A/mallard/MN/382/2000(H5N3)) 
ABV25998 347 H5N3 2000 Influenza A virus (A/mallard/MN/479/2000(H5N3)) 
ABV25999 529 H5N3 1975 Influenza A virus (A/mallard/Wl/169/1975(H5N3)) 
AAC58994 548 H5N3 1975 Influenza A virus (A/mallard/Wisconsin/169n5(H5N3)) 
ABB87281 564 H5N3 1989 Influenza A virus 0,'herring gull/NJ/402/1989(H5N3)) 
ABV26000 564 H5N5 2000 Influenza A virus (A/mallard/MN/105/2000(H5N5)) 
AAC58993 332 H5N6 1975 Influenza A virus (A/mallard/Wisconsin/34/1975(H5N6)) 
ABB87292 564 H5N7 2004 Influenza A virus (A/shorebird/DE/101/2004(H5N7)) 
ABB87711 564 H5N7 2004 Influenza A virus (A/shorebird/DEn5/2004(H5N7)) 
ABV26001 564 H5N7 2001 Influenza A virus (A/shorebird/DE/1346/2001(H5N7)) 
ABV26002 494 H5N7 20 4 Influenza A virus (A/ruddy tu_l'nstonc/NJ/ l 148676/2004(H5N7)) 
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ABV26003 346 H5N7 
ABV26004 348 H5N7 
ABV26005 347 H5N8 
AAP72011 548 H5N8 
AAC58998 548 H5N9 
AAC58999 564 H5N9 
2001 Influenza A virus (A/ruddy turnstone_/NJ/1698/2001(H5N7)) 
2001 Influenza A virus (A/rudd� turnstone/NJ/1851/2001(H5N7)) 
2001 Influenza A virus (A/rudd� turnstone/DE/2046/2001(H5N8)) 
2002 Influenza A virus (A/duck/NY/191255-59/02(H5N8)) 
1968 Influenza A virus (A/turkey/Wisconsin/1968(H5N9)) 
1987 Influenza A virus (A/mallard/Ohio/556/1987(H5N9)) 
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Score 4.543 length 13 at 
AAB39639 residues 4-> 16 
ABW96332 No scores over 3.50 
ABW96333 No scores over 3.50 
ABW96334 No scores over 3.50 
Score 4.317 length 13 at 
ABV26006 residues 530->542 
Score 5.151 length 13 at 
AAD13572 residues 4-> 16 
Score 5.151 length 13 at 
AAD13575 residues 4->16 
Score 4.317 length 13 at 
ABV25966 residues 530->542 
Score 4.317 length 13 at 
ABV25967 residues 530->542 
Score 4.317 length 13 at 
ABV25968 residues 530->542 
Score 4.317 length 13 at 
ABV25969 residues 530->542 
AAC58995 No scores over 3.50 
Score 5.151 length 13 at 
ABI84608 residues 4-> 16 
Score 4.317 length 13 at 
ABJl6565 residues 530->542 
Score 4.317 length 13 at 
ABX88799 residues 530->542 
Score 4.317 length 13 at 
AAA43094 residues 530->542 
Score 4.317 length 13 at 
ABI84603 residues 530->542 
Score 5.151 length 13 at 
BAF48359 residues 4-> 16 
AAF89536 No scores over 3.50 
AAF89537 No scores over 3.50 
AAF89538 No scores over 3.50 
AAF89539 No scores over 3.50 
AAF89540 No scores over 3.50 
AAF89541 No scores over 3.50 
AAF89542 No scores over 3.50 
AAF89543 No scores over 3.50 
Score 4.317 length 13 at 
residues 530->542 
NP* 
NP* 
NP* 
NP* 
Score 4.317 length 13 at 
residues 530->542 
Score 4.317 length 13 at 
residues 530->542 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
Score 4.317 length 13 at 
residues 530->542 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
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pos. 16 and 17 
pos. -1 and 0 
pos. -1 and 0 
pos. -1 and 0 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. -land 0 
pos. -1 and 0 
pos. -land 0 
pos. -1 and 0 
pos. -1 and 0 
pos. -1 and 0 
pos. -1 and 0 
pos. -land 0 
0.157 
0 
0 
0 
0.205 
0.244 
0.244 
0.173 
0.173 
0.173 
0.173 
,0 
0.244 
0.173 
0.173 
0.048 
0.173 
0.244 
0 
0 
0 
0 
0 
0 
0 
0 
pos. 16 and 
17 
NP* 
NP* 
NP* 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
NP* 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
AAF89544 No scores over 3.50 NP* 
AAF89545 No scores over 3.50 NP* 
AAF89546 No scores over 3.50 NP* 
Score 4.317 length 13 at 
AAC58996 residues 514->526 NP* 
Score 4.317 length 13 at 
AAC58997 residues 514->527 NP* 
Score 5.111 length 13 at 
AAC58991 residues 514->526 NP* 
AAC58992 No scores over 3.50 NP* 
Score 5.151 length 13 at Score 4.317 length 13 at 
ABI84784 residues 4->16 residues 530->542 
Score 4.317 length 13 at 
ABI84816 residues 530->542 NP* 
Score 4.317 length 13 at 
ABI85095 residues 530->542 NP* 
Score 4.317 length 13 at 
AB880546 residues 530->542 NP* 
AA882064 No scores over 3.50 NP* 
AAA74909 No scores over 3.50 NP* 
AAA74910 No scores over 3.50 NP* 
AAC54390 No scores over 3.50 NP* 
AAC54391 No scores over 3.50 NP* 
AAC54392 No scores over 3.50 NP* 
Score 4.317 length 13 at 
AA849654 residues 514->526 NP* 
Score 4.317 length 13 at 
AAB49655 residues 516->528 NP* 
Score 4.317 length 13 at 
ABV25970 residues 530->542 NP* 
Score 4.317 length 13 at 
ABV25971 residues 530->542 NP* 
Score 4.317 length 13 at 
ABV25972 residues 530->542 NP* 
Score 4.317 length 13 at 
ABV25973 residues 530->542 NP* 
Score 4.317 length 13 at 
ABV25974 residues 530->542 NP* 
Score 4.317 length 13 at 
ABV25975 residues 530->542 NP* 
Score 4.317 length 13 at 
ABV25976 residues 530->542 NP* 
Score 4.317 length 13 at 
ABV25977 residues 530->542 NP* 
Score 4.317 length 13 at 
ABV25978 residues 530->542 NP* 
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eos. -1 and 0 
eos. -1 and 0 
eos. -1 and 0 
eos. -1 and 0 
pos. -1 and 0 
eos. -1 and 0 
eos. 15 and 16 
eos. 16 and 17 
120s. 16 and 17 
eos. 16 and 17 
eos. 16 and 17 
eos. 15 and 16 
pos. 15 and 16 
eos. 15 and 16 
eos. 27 and 28 
eos. 27 and 28 
pos. 27 and 28 
eos. -1 and 0 
eos. -1 and 0 
eos. 16 and 17 
pos. 16 and 17 
eos. 16 and 17 
eos. 16 and 17 
eos. 16 and 17 
pos. 16 and 17 
eos. 16and 17 
eos. 16 and 17 
pos. 16 and 17 
0 
0 
0 
0 
0 
0 
0 
0.244 
0.173 
0.123 
0.261 
0 
0 
0 
0.001 
0.001 
0.001 
0 
0 
0.173 
0.173 
0.173 
0.205 
0.173 
0.173 
0.173 
0.173 
0.173 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
eos. 16 and 17 
pos. 16 and 17 
eos. 16 and 17 
eos. 16 and 17 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
pos. 16 and 17 
pos. 16 and 17 
eos. 16 and 17 
eos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
eos. 16 and 17 
eos. 16 and 17 
pos. 16 and 17 
Score 4.317 length 13 at 
ABV25979 residues 530->542 NP* 
Score 4.317 length 13 at 
ABV25980 residues 530->542 NP* 
Score 4.317 length 13 at 
ABV25981 residues 530->542 NP* 
Score 4.317 length 13 at 
ABV25982 residues 530->543 NP* 
Score 5.555 length 13 at 
ABV25983 residues 4-> 16 NP* 
ABV25984 No scores over 3.50 NP* 
Score 4.317 length 13 at 
ABV25985 residues 530->542 NP* 
ABV25986 No scores over 3.50 NP* 
ABV25987 No scores over 3.50 NP* 
Score 4.317 length 13 at 
ABV25988 residues 530->543 NP* 
ABV25989 No scores over 3.50 NP* 
ABV25990 No scores over 3.50 NP* 
ABV25991 No scores over 3.50 NP* 
ABV25992 No scores over 3.50 NP* 
Score 4.317 length 13 at 
ABV25993 residues 530->542 NP* 
ABV25994 No scores over 3.50 NP* 
Score 4.317 length 13 at 
ABV25995 residues 530->542 NP* 
Score 4.317 length 13 at 
ABV26007 residues 530->542 NP* 
Score 4.317 length 13 at 
ABV25996 residues 530->542 NP* 
Score 5.151 length 13 at Score 4.317 length 13 at 
AAF04719 residues 4-> 16 residues 530->542 
Score 5.151 length 13 at Score 4.317 length 13 at 
AAF04720 residues 4-> 16 residues 530->542 
Score 4.317 length 13 at 
AAP71989 residues 530->542 NP* 
Score 3.997 length 7 at 
AAP71990 residues 1->7 NP* 
AAP71994 No scores over 3.50 NP* 
Score 4.317 length 13 at Score 4.186 length 13 at 
AAP71995 residues 530->542 residues 547->559 
Score 4.317 length 13 at Score 4.186 length 13 at 
AAP71996 residues 530->542 residues 547->559 
Score 4.317 length 13 at Score 4.186 length 13 at 
AAP71997 residues 530->543 residues 547->560 
Score 4.186 length 13 at 
AAP71998 residues 547->559 NP* 
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pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. -1 and 0 
pos. -1 and 0 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 13 and 14 
pos. -1 and 0 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
0.173 
0.055 
0.173 
0.173 
0.807 
0.25 
0.173 
0.406 
0.59 
0.173 
0.578 
0.582 
0 
0 
0.18 
0.582 
0.173 
0.135 
0.173 
0.244 
0.244 
0.173 
O.G2 
0
0.173 
0.173 
0.173 
0.173 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
NP* 
NP* 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 13 and 14 
NP* 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
AAP71999 No scores over 3.50 
Score 4.317 length 13 at 
AAP72002 residues 530->542 
Score 4.317 length 13 at 
AAP72004 residues 514->526 
Score 4.317 length 13 at 
AAP72005 residues 530->542 
Score 4.317 length 13 at 
AAP72006 residues 514->526 
Score 4.317 length 13 at 
AAP72007 residues 514->526 
Score 4.317 length 13 at 
AAP72008 residues 514->526 
AAK57506 No scores over 3.50 
AALl6033 No scores over 3.50 
Score 4.422 length 13 at 
AAX47288 residues 530->542 
Score 4.317 length 13 at 
ABG88245 residues 530->542 
Score 4.317 length 13 at 
ABW94105 residues 530->542 
Score 5.151 length 13 at 
ABW97492 residues 4->16 
Score 4.317 length 13 at 
AAA43159 residues 513->525 
Score 4.317 length 13 at 
AAA43160 residues 513->525 
Score 4.317 length 13 at 
AAP72009 residues 514->526 
Score 4.422 length 13 at 
AAP72010 residues 514->526 
ABV25997 NP* 
ABV25998 NP* 
ABV25999 NP* 
AAC58994 NP* 
ABB87281 NP* 
Score 4.317 length 13 at 
ABV26000 residues 530->542 
AAC58993 No scores over 3.50 
Score 4.317 length 13 at 
ABB87292 residues 530->542 
Score 4.317 length 13 at 
ABB8771 I residues 530->542 
Score 5.555 length 13 at 
ABV26001 residues 4-> 16 
ABV26002 No scores over 3.50 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
Score 4.186 length 13 at 
residues 547->559 
Score 4.317 length 13 at 
residues 530->542 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
NP* 
Score 4.317 length 13 at 
residues 530->542 
NP* 
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pos. 15 and 16 
pos. 16 and 17 
pos. -1 and 0 
pos. 16 and 17 
pos. -1 and 0 
pos. -1 and 0 
pos. -1 and 0 
pos. -1 and 0 
pos. -1 and 0 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. -1 and 0 
pos. -1 and 0 
pos. -1 and 0 
pos. -1 and 0 
pos. 16 and 17 
pos. 16 and 17 
pos. -1 and 0 
pos. -1 and 0 
pos. 16 and 17 
pos. 16 and 17 
pos. -1 and 0 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
0 
0.052 
0 
0.173 
0 
0 
0 
0 
0 
0.043 
0.173 
0.173 
0.244 
0 
0 
0 
0 
0.466 
0.582 
0 
0 
0.244 
0.173 
0 
0.173 
0.173 
0.434 
0.279 
NP* 
pos. 16 and 17 
NP* 
pos. 16 and 17 
NP* 
NP* 
NP* 
NP* 
NP* 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
NP* 
NP* 
NP* 
NP* 
pos. 16 and 17 
pos. 16 and 17 
NP* 
NP* 
pos. 16 and 17 
pos. 16 and 17 
NP* 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
Score 5.555 length 13 at 
ABV26003 residues 4->16 NP* 
Score 5.555 length 13 at 
ABV260 4 residues 4-> 16 NP* 
Score 5.555 length 13 at 
ABV26005 residues 4-> 16 NP* 
Score 4.317 length 13 at 
AAP7201l residues 514->526 NP* 
Score 4.317 length 13 at 
AAC58998 residues 530->542 NP* 
Score 4.317 length 13 at 
AAC58999 residues 530->542 NP* 
NP* indicates Not Predicted entry. 
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pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
pos. -1 and 0 
pos. -l and 0 
eos. 16 and 17 
0.808 
0.806 
0.807 
0 
0 
0.072 
pos. 16 and 17 
pos. 16 and 17 
pos. 16 and 17 
NP* 
NP* 
pos. 16 and 17 
AAB39639 
ABW96332 
ABW96333 
ABW96334 
ABV26006 
AAD13572 
AAD13575 
ABV25966 
ABV25967 
ABV25968 
ABV25969 
AACS8995 
ABI84608 
ABJ16565 
ABX88799 
AAA43094 
ABI84603 
BAF48359 
AAF89536 
AAF89537 
AAF89538 
AAF89539 
AAF89540 
AAF89541 
AAF89542 
AAF89543 
r, "� 
APPENDIX TABLE C 
Pathogenic NIA* 
NIA* NIA* 
NIA* NIA* 
NIA* NIA* 
Low-Pathogenic RETR/G 
NIA* NIA* 
NIA* NIA* 
Low-Pathogenic RETR/G 
Low-Pathogenic RETR/G 
Low-Pathogenic RETR/G 
Low-Pathogenic RETR/G 
Low-Pathogenic NIA* 
NIA* NIA* 
NIA* NIA* 
NIA* NIA* 
Low-Pathogenic PQKKKR/GLF 
NIA* NIA* 
NIA* NIA* 
Pathogenic NIA* 
Pathogenic NIA* 
Pathogenic NIA* 
NIA* NIA* 
NIA* NIA* 
NIA* NIA* 
NIA* NIA* 
NIA* NIA* 
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AAF89544 NIA* NIA* 
AAF89545 NIA* NIA* 
AAF89546 NIA* NIA* 
AAC58996 Low-Pathogenic NIA* 
AACS8997 Low-Pathogenic NIA* 
AACS8991 Non-Pathogenic NIA* 
AACS8992 Low-Pathogenic NIA* 
ABI84784 NIA* NIA* 
ABI84816 NIA* NIA* 
ABI85095 Low-Pathogenic PQKKKR/GLF 
ABB80546 NIA* NIA* 
AAB82064 Non-Pathogenic R-E-T-R
AAA74909 Non-Pathogenic R-E-T-R
AAA74910 Non-Pathogenic R-K-T-R
AACS4390 NIA* NIA* 
AACS4391 Non-Pathogenic R-E-T-R
AAC54392 Non-Pathogenic R-E-T-R
AAB49654 Low-Pathogenic RETR/G 
AAB49655 Low-Pathogenic RETR/G 
ABV25970 Low-Pathogenic RETR/G 
ABV25971 Low-Pathogenic RETR/G 
ABV25972 Low-Pathogenic RETR/G 
ABV25973 Low-Pathogenic RETR/G 
ABV25974 Low-Pathogenic RETR/G 
ABV25975 Low-Pathogenic RETR/G 
ABV25976 Low-Pathogenic RETR/G 
ABV25977 Low-Pathogenic RETR/G 
ABV25978 Low-Pathogenic RETR/G 
75 
ABV25979 Low-Pathogenic RETR/G 
ABV25980 Low-Pathogenic RETR/G 
ABV25981 Low-Pathogenic RETR/G 
ABV25982 Low-Pathogenic RETR/G 
ABV25983 Low-Pathogenic RGTR/G 
ABV25984 Low-Pathogenic RETR/G 
ABV25985 Low-Pathogenic RETR/G 
ABV25986 Low-Pathogenic RETR/G 
AHV25987 Low-Pathogenic RETR/G 
ABV25988 Low-Pathogenic RETR/G 
ABV25989 Low-Pathogenic RETR/G 
ABV25990 Low-Pathogenic RETR/G 
ABV25991 Low-Pathogenic RETR/G 
ABV25992 Low-Pathogenic RETR/G 
ABV25993 Low-Pathogenic RETR/G 
ABV25994 Low-Pathogenic RETR/G 
ABV25995 Low-Pathogenic RETR/G 
ABV26007 NIA* NIA* 
ABV25996 Low-Pathogenic RETR/G 
AAF04719 Non-Pathogenic NIA* 
AAF04720 Non-Pathogenic NIA* 
AAP71989 Low-Pathogenic RETR/G 
AAP71990 Low-Pathogenic RETR/G 
AAP71994 Low-Pathogenic RETR/G 
AAP71995 Low-Pathogenic RETR/G 
AAP71996 Low-Pathogenic RETR/G 
AAP71997 Low-Pathogenic RETR/G 
AAP71998 Low-Pathogenic RETR/G 
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AAP71999 Low-Pathogenic RETR/G 
AAP72002 Low-Pathogenic RETR/G 
AAP72004 Low-Pathogenic RETR/G 
AAP72005 Low-Pathogenic RETR/G 
AAP72006 Low-Pathogenic RETR/G 
AAP72007 Low-Pathogenic RETR/G 
AAP72008 Low-Pathogenic RETR/G 
AAK57506 N/A* N/A* 
AAL16033 N/A* N/A* 
AAX47288 Pathogenic PQ---RKKR 
ABG88245 N/A* N/A* 
ABW94105 Low-Pathogenic RETR/G 
ABW97492 N/A* N/A* 
AAA43159 Pathogenic PQ---KKKR 
AAA43160 Low-Pathogenic PQKKKR/GLF 
AAP72009 Low-Pathogenic RETR/G 
AAP72010 Pathogenic PQREKR/GLF 
ABV25997 Low-Pathogenic RETR/G 
ABV25998 Low-Pathogenic RETR/G 
ABV25999 Low-Pathogenic RETR/G 
AAC58994 Low-Pathogenic N/A* 
ABB87281 N/A* N/A* 
ABV26000 Low-Pathogenic N/A* 
AAC58993 Low-Pathogenic N/A* 
ABB87292 N/A* N/A* 
ABB87711 N/A* N/A* 
ABV26001 Low-Pathogenic RGTR/G 
ABV26002 Low-Pathogenic RETR/G 
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#!usr/bin/perl; 
$instr= $ARGV[O]; 
open (IN, $instr) or 
die "Cannot read the file:$!"; 
while( <IN>) 
{ 
my $header=$_; 
if ($header =- /"\>/) 
{ 
APPENDIXD 
print ("Header of the file is $instr is \n$header"); 
} 
} 
else 
{ 
my $Sequence = $_; 
print ("Sequence of the file is $instr is \n$Sequence"); 
} 
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